What is the most likely diagnosis for a patient with a documented bloodstream infection‑related condition (BCF) who develops fever during a dialysis session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Catheter-Related Bloodstream Infection (CRBSI)

The most likely diagnosis for a patient with a bloodstream infection-related condition (BCF) who develops fever during dialysis is catheter-related bloodstream infection (CRBSI), which occurs in approximately 60% of hemodialysis patients presenting with fever or chills during dialysis sessions. 1, 2

Diagnostic Criteria

The diagnosis of CRBSI in hemodialysis patients is established using standardized IDSA criteria that account for the unique circumstances of dialysis patients 3:

  • Clinical manifestations (fever, chills, hypotension) with at least one positive blood culture from a peripheral source (dialysis circuit or vein) and no other apparent source of infection 3
  • Microbiologic confirmation requires isolation of the same organism (species and antibiogram) from both the catheter segment (hub or tip with >15 CFU by roll-plate or >10² CFU by quantitative culture) and a peripheral blood sample 3
  • Supportive findings include simultaneous quantitative blood cultures with a ratio ≥3:1 (catheter vs peripheral) or differential time to positivity of ≥2 hours 3

Immediate Diagnostic Workup

Obtain at least two sets of blood cultures before initiating antibiotics—one from the catheter AND one from a peripheral site or dialysis circuit bloodlines. 4, 1

Key clinical assessments to perform immediately 4, 1:

  • Inspect the catheter exit site for erythema, warmth, purulent drainage, or signs of tunnel infection
  • Assess for hemodynamic instability, septic shock, or organ dysfunction
  • Examine for complications including endocarditis, suppurative thrombophlebitis, or metastatic infection

Pathogen Profile and Risk Stratification

The most common causative organisms are 1, 5:

  • Coagulase-negative staphylococci and Staphylococcus aureus (most frequent, 77% methicillin-resistant in some cohorts)
  • Gram-negative bacilli including Enterobacter, Pseudomonas, Stenotrophomonas, and Acinetobacter
  • Candida species (associated with higher complication rates)

Patients with vascular catheters have 6.2 times higher odds of bacteremia compared to those with fistulas or grafts (OR 6.2; 95% CI 3.2-12.0). 2

Risk Factors for Infection

Multivariate analysis identifies specific predictors 2, 5:

  • Fever during dialysis (OR 1.6; 95% CI 1.1-2.3) increases bacteremia risk
  • Vascular catheter access (OR 6.2; 95% CI 3.2-12.0) versus fistula/graft dramatically elevates risk
  • Leukocytosis (OR 1.265; 95% CI 1.113-1.438) predicts any infection
  • Hypoalbuminemia increases BSI risk by 1.7-fold
  • Hyperemia at catheter insertion site is present in 64.9% of BSI cases

Clinical Context and Prognosis

Approximately 60% of hemodialysis patients presenting with chills during dialysis have a documented infection, with 33.5% having bacteremia. 2

The mortality rate in this population reaches 20%, underscoring the importance of prompt recognition and treatment 5. The high frequency of multiresistant bacteria (77.7% methicillin-resistant staphylococci in some series) necessitates broad-spectrum empirical coverage 5.

Low-Risk Exception

Only patients with fistula or graft access who present without fever, leukocytosis, or hypoalbuminemia have sufficiently low bacteremia risk (6%) to potentially defer immediate antibiotics pending culture results. 2 All other patients require immediate empirical antibiotic therapy after blood cultures are obtained 1, 2.

Common Pitfalls to Avoid

  • Do not routinely remove catheters in hemodynamically stable patients without documented bloodstream infection, as the majority of suspected catheters are sterile 3
  • Do not use procalcitonin to rule out infection in dialysis patients—it has only 77% sensitivity and 59% specificity at cutoff ≥1 ng/ml, which is insufficient for clinical decision-making 6
  • Do not delay blood cultures to obtain them from "ideal" sites—blood can be drawn from dialysis circuit bloodlines if peripheral access is unavailable 4, 1
  • Do not forget to culture the catheter tip if removed, as this provides definitive microbiologic diagnosis 3, 7

References

Guideline

Management of Chills During Hemodialysis in a Catheter Patient

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chills During Dialysis with Reused Dialyzer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.